As more people turn to telehealth for GLP-1s, one type of pharmacy is coming under scrutiny.

The LegitScript-certified telehealth platform's new plan bills $375 every three months for compounded tirzepatide with B12, ...

A strategic letter of intent with an established U.S. 503A compounding pharmacy gives The More Life Company (CSE: MLCO, OTC: ...

The More Life Company (MLCO.CN) entered into a non-binding letter of intent (LOI) with a US 503A compounding pharmacy to advance the development, compounding and commercialization of its Quicksome ...

As certain prescription medicines gain increasing attention online, concerns have also emerged over Filipinos obtaining ...

If used, the drugs could cause a serious reaction.

A child who cannot swallow a pill. A patient allergic to an ingredient in a standard prescription. A medication that manufacturers have stopped making altogether. These are the kinds of challenges ...

The More Life Company Corp. (the "Company" or "MLCO"), (CSE: MLCO) (OTC: TMLCF) is pleased to announce that it has entered into a strategic letter of intent ("LOI") with an established U.S. 503A ...

Food and Drug Administration scientists and some medical experts have raised alarms about increasing access to certain ...

The successes of the GLP-1 class for chronic weight management “introduced consumer overlay over a historically physician-driven therapeutic area,” Pothier explained, noting that despite the potency ...

In late July, an FDA advisory panel did something rare. It voted to loosen the rules. The Pharmacy Compounding Advisory Committee recommended letting ...